Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
View graph of relations

Curriculum

Name Gorm Greisen, born 1951

Current workplace: Rigshospitalet, Department of Neonatology

 

Education

1982 – 1989 Dr.Med.Sc. Faculty of Health Sciences, University of Copenhagen

1977 – 1978 Diploma of tropical medicine, Institute ‘Prince Leopold’, Antwerpen

1969 – 1976 Cand. Med. Faculty of Health Sciences, University of Copenhagen

1971 - 1974 B.Sc. (computer science) University of Copenhagen

 

Employments

2013 - 2019 Chairman of paediatrics, University of Copenhagen

2009 - 2012 Deputy head of the Institute of gynecology, obstetrics and paediatrics, University of Copenhagen.

2001 - 2012 Head of Department, Neonatology, Rigshospitalet

1998 – Professor of Paediatrics, University of Copenhagen

1991 - Consultant neonatologist, Rigshospitalet

 

Research profile and leadership experience

Heading research in neonatal brain perfusion, oxygenation, brain injury, and neurodevelopmental deficits and perinatal growth. Primary investigator in the SafeBoosC project. Clinical coordinator of the NEOMUNE project. Steering committee member in four European research and educational projects. President for the European Society of Paediatric research and for the International Pediatric Research Foundation. Chairman of a regional research ethics committee. Chairman of The Danish Council of Ethics.

 

Honours

2017 Kleins award

2014 Knight of the order of Dannebrog

2008 The bi-annual National Research Ethics Committee award

2007 William Ottesen travel award

1994 Danin Foundation award

 

Other scientific qualifications

Invited speaker at more than 100 international meetings. Organiser of the European society of Paediatric Research conference 1999, chairman of the scientific committee 2013. Supervisor for more than 30 phd-students.

Publications: More than 350 in PubMed, in WebofScience: H-index 49, total citations more than 7500

Patents: None

Main research areas

  • Causes of brain injury in preterm infants
  • Cerebral blood flow and cerebral oxygenation
  • Systematic follow-up studies to evaluate outcomes later in life
  • Growth before and after birth
  • Consequences of growth in the perinatal period for later health
  • Interventions in the newborn period to improve health later in life
  • Ethics of medical research.

Potential conflicts of interest

I do not have bonds or other economic interests in any health care industry, except for what may – at any given moment - be part of the investment funds that I and my wife hold. I do not hold any patents.

1. I had a long-standing relation with Radiometer Medical involving measurement of lactate, glucose, bilirubin and blood gases, transcutaneous pO2 and pCO2 and near-infrared spectroscopy. During these project Radiometer has provided material and payed other costs. I have not held any personal salary or benefit.

2. I was a member of the ‘Curosurf family’, and as such invited by Serono and Chiesi to a series of European meetings on surfactant replacement until 1996. In 2006 I participated in a task force on the development of a European guideline for the treatment of respiratory distress syndrome that was sponsored by Chiesi. This was repeated in 2010, 2012, and 2016. I did not receive a honorarium.

3. I held a research contract - on behalf of an academic group - with Novo Nordic A/S with a total value of 3 mio Dkk in the period 2002-5 with the purpose of studying the effect of third trimester fetal growth of metabolic and endocrine health in adolescence. I did not hold any personal salary or benefit.

4. I served as a member of the Data Management and Safety Committee during a proof-of concept study of a selective oxitocin antagonist conducted by Ferring in the period from 2003-7. My per-hour honorarium was payed to an account for educational purposes at the clinic of neonatology.

Vested interests

1. I have provided care to ill and immature newborn infants for many years and want to see this as meaningful.

2. I am employed in a public hospital that needs to choose among worthy services to deliver. Therefore I see value for money as a necessary criterion.

ID: 9263